Anne Wojcicki The new offer prohibits 23ndme private for $ 74.7 million

23andme According to Friday, the General Director Anne Wojcicki and New Mountain Capital submitted a proposal to take a private genetic testing company, according to Friday filing with the American Commission for Securities and Exchange.

Wojcicki and New Mountain offered the purchase of all other 23andme shares in cash for USD 2.53 per share or capital value in the amount of approximately USD 74.7 million. The Company's shares ended on Friday each of USD 2.42 with a market capital of approximately USD 65 million.

The offer appears after a turbulent year for 23ndme, and shares lose over 80% of their value in 2024. In January, the company announced Examination plans Strategic alternativeswhich may include the sale of a company or its assets, restructuring or business combination.

23andme has a special committee of independent directors to evaluate potential paths forward. The company appointed three new independent directors of the management board in October after all seven previous directors Suddenly he gave up Previous month. The special committee must be approved by Wojcicki and the New Mountain proposal.

“We believe that our proposal provides important value and immediate liquidity to public shareholders,” wrote Wojcicki and Matthew Holt, managing director and president of Private Equity in New Mountain on Thursday to the Special Committee.

Wojcicki had made a proposal earlier Take a private company for 40 cents per action in July, but it was rejected By the Special Committee, partly because the members found that it lacked financing and did not constitute a closure price bonus at the time.

Wojcicki and New Mountain are ready to provide secured debt financing to finance 23andme activities by closing the transaction. According to her New Mountain, he has its headquarters in New York and has $ 55 billion website.

23andme refused to comment.

TO WATCH: Height and fall 23andme